Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
2-Methyl-1-[2-[1-(methyl-d3)ethyl-1,2,2,2-d4]pyrazolo[1,5-a]pyridin-3-yl]-1-propanone
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Ibudilast-d7 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Ibudilast-d7 usage and description
Ibudilast D7 is a deuterated derivative of Ibudilast, a drug that has been used in Japan for over 20 years to treat asthma, stroke, and other neurological conditions. Ibudilast D7 is a selective inhibitor of phosphodiesterase-4 (PDE4), an enzyme that degrades cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in cells. This inhibition of PDE4 increases levels of cAMP and cGMP, leading to a reduction in inflammation and other cellular responses.
Ibudilast D7 has been used in preclinical research to study the effects of PDE4 inhibition on various diseases, including multiple sclerosis, Alzheimer's disease, and substance abuse disorders. It has shown promise in reducing inflammation and neurodegeneration, and has been suggested as a potential treatment for these conditions.
Chemically, Ibudilast D7 is a labeled compound, meaning that it contains seven deuterium atoms instead of hydrogen atoms. This labeling allows for easier detection and quantification of the drug in biological samples. The chemical formula of Ibudilast D7 is C14H8D7N2O, and its molecular weight is 216.29 g/mol.
In conclusion, Ibudilast D7 is a selective PDE4 inhibitor that has shown promise in preclinical research for the treatment of various diseases. Its chemical labeling allows for easier detection and quantification, making it a valuable tool in research.
